RxNews Recap for 04-08-11 Print E-mail
By Staff and Wire Reports   
Friday, 08 April 2011 19:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 08, 2011.

Axia Group (PINKSHEETS:AGIJ) (www.axiacorporation.com) subsidiary Collagenna Skin Care Products/Melem Secret announce that the company finalized its Collagen Infusion Technology, and that the updated technology will become a part of the company current marketing efforts.

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, announced today that it has executed an agreement for the sale of 320,000 shares of its common stock at $5.60 per share to institutional investors in a registered direct offering for approximately $1.80 million in gross proceeds.

Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a webcast of their corporate presentation at BioCentury's Future Leaders in the Biotech Industry conference at 8:30 AM (ET) on Friday, April 15, 2011 in New York.

Innovative Health Sciences, Inc. (PINKSHEETS:IHSN) announced today that it has restructured its agreement with Harrington Multi Media Marketing (HM3).

Medical Marijuana, Inc. (PINKSHEETS:MJNA) in association with CannaBANK™ is proud to announce the appointment of the Medical Marijuana, Inc. Board of Directors (members to be announced April 15th, 2011) to oversee day-to-day operations, the formation of the CannaBANK Advisory Team to supervise and resolve issues related to compliance and facility management and a new management team ensuring continued smooth operations during this transitional period.

Medgenics, Inc. (NYSE Amex:MDGN) (NYSE Amex: MDGN.W) (AIM: MEDG) (AIM: MEDU), the company that has developed a novel technology for the sustained manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, today announced the pricing of its initial underwritten public offering in the United States of 2,460,000 Common Shares, having a par value of US $0.0001 each (the "Common Stock"), and redeemable Common Stock purchase warrants to purchase 2,460,000 shares of additional Common Stock (the "Warrants"), at a price to the public of $4.54 per share of Common Stock and $0.46 per corresponding Warrant, or an aggregate price of $5.00 for the combination of one share and one Warrant.

Rotoblock Corp. (OTCBB: RTBC), a publicly-owned California-based corporation investing in emerging technology opportunities in China, appointed Michael Choy and Andrew Chow to its Board of Directors.

Transax International Limited  (OTCQB:TNSX) (PINKSHEETS: TNSX), a network solutions company for healthcare providers and health insurance companies, today reported the sale of its operating subsidiary, Medlink Conectividade Em Saúde Ltda ("Medlink") located in Brazil to QC Holding I Participações s.a ("the Buyer"), a subsidiary of Qualicorp a Brazilian Healthcare company.



"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter